Figure-01 (Figure 01)
This text appears to be presenting information related to a study or evaluation involving the use of a medication called Atorvastatin compared to a placebo. The text includes percentages related to cumulative incidence, a hazard ratio value, and the duration of the study, which is noted as 3.5 years.*